These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical forms of severe tardive dyskinesia. Gardos G; Cole JO; Salomon M; Schniebolk S Am J Psychiatry; 1987 Jul; 144(7):895-902. PubMed ID: 2886062 [TBL] [Abstract][Full Text] [Related]
5. [Deanol in tardive dyskinesia: a double-blind study (author's transl)]. Bockenheimer S; Lucius G Arch Psychiatr Nervenkr (1970); 1976 Sep; 222(1):69-75. PubMed ID: 791197 [TBL] [Abstract][Full Text] [Related]
7. [Tardive dyskinesia induced by neuroleptics. A review of the literature]. Diepart E; Cottereau MJ; Deniker P Encephale; 1979; 5(4):317-37. PubMed ID: 42528 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of 37 cases of tardive dyskinesia by deanol]. Cai N Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):234-6. PubMed ID: 4075918 [No Abstract] [Full Text] [Related]
9. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia]. Kocher R; Hobi V; Linder M; Studer K Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283 [TBL] [Abstract][Full Text] [Related]
10. Lithium carbonate in the treatment of movement disorders. A critical review. Yassa R; Ananth J Int Pharmacopsychiatry; 1980; 15(5):301-8. PubMed ID: 6114936 [TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia: characterization and prevalence in a statewide system. Bell RC; Smith RC J Clin Psychiatry; 1978 Jan; 39(1):39-47. PubMed ID: 580260 [TBL] [Abstract][Full Text] [Related]
12. [Dimethylaminoethanol in the treatment of neuroleptic-induced tardive dyskinesia]. Lambert PA; Wolff P; de Maximy B; Ghenim A Ann Med Psychol (Paris); 1978 Apr; 136(4):625-9. PubMed ID: 31832 [No Abstract] [Full Text] [Related]
14. [Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital]. Bourgeois M Encephale; 1977; 3(4):299-320. PubMed ID: 611013 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients. Richardson MA; Haugland G; Craig TJ Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296 [TBL] [Abstract][Full Text] [Related]
16. Prevention and management of tardive dyskinesia. Jeste DV; Wyatt RJ J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473 [TBL] [Abstract][Full Text] [Related]
17. Deanol acetamidobenzoate (Deaner) in tardive dyskinesia. Stafford JR; Fann WE Dis Nerv Syst; 1977 Dec; 38(12 Pt 2):3-6. PubMed ID: 590063 [TBL] [Abstract][Full Text] [Related]
18. Not all that moves is tardive dyskinesia. Khot V; Wyatt RJ Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323 [TBL] [Abstract][Full Text] [Related]
19. Treatment of neuroleptic induced tardive dyskinesia with cyproheptadine. Kurata K; Hosokawa K; Koshino Y J Neurol; 1977 Jul; 215(4):295-8. PubMed ID: 70522 [No Abstract] [Full Text] [Related]
20. Diphenhydramine in the differential diagnosis of neuroleptic-induced oral-facial dyskinesia. Beitman BD Am J Psychiatry; 1977 Jun; 134(6):695-6. PubMed ID: 869040 [No Abstract] [Full Text] [Related] [Next] [New Search]